212 related articles for article (PubMed ID: 22670880)
21. ALS clinical trials: do enrolled patients accurately represent the ALS population?
Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G;
Neurology; 2011 Oct; 77(15):1432-7. PubMed ID: 21956723
[TBL] [Abstract][Full Text] [Related]
22. The predictors of survival in Chinese amyotrophic lateral sclerosis patients.
Wei Q; Chen X; Zheng Z; Guo X; Huang R; Cao B; Zeng Y; Shang H
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):237-44. PubMed ID: 25581512
[TBL] [Abstract][Full Text] [Related]
23. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
Peysson S; Vandenberghe N; Philit F; Vial C; Petitjean T; Bouhour F; Bayle JY; Broussolle E
Eur Neurol; 2008; 59(3-4):164-71. PubMed ID: 18230874
[TBL] [Abstract][Full Text] [Related]
24. Clinical aspects of amyotrophic lateral sclerosis in Rio de Janeiro/Brazil.
Loureiro MP; Gress CH; Thuler LC; Alvarenga RM; Lima JM
J Neurol Sci; 2012 May; 316(1-2):61-6. PubMed ID: 22342397
[TBL] [Abstract][Full Text] [Related]
25. Evidence of an environmental effect on survival in ALS.
Keren N; Scott KM; Tsuda M; Barnwell J; Knibb JA; Ellis CM; Leigh PN; Shaw CE; Al-Chalabi A
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):528-33. PubMed ID: 24862874
[TBL] [Abstract][Full Text] [Related]
26. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.
Cellura E; Spataro R; Taiello AC; La Bella V
Clin Neurol Neurosurg; 2012 Jul; 114(6):550-4. PubMed ID: 22169158
[TBL] [Abstract][Full Text] [Related]
28. Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.
Lunetta C; Lizio A; Melazzini MG; Maestri E; Sansone VA
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):93-100. PubMed ID: 26470943
[TBL] [Abstract][Full Text] [Related]
29. Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - data from a population-based registry.
Wolf J; Safer A; Wöhrle JC; Palm F; Nix WA; Maschke M; Grau AJ
J Neurol Sci; 2014 Oct; 345(1-2):164-7. PubMed ID: 25086855
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in amyotrophic lateral sclerosis].
Martí-Fàbregas J; Pradas J; Illa I
Neurologia; 1996 May; 11(5):174-81. PubMed ID: 8754633
[TBL] [Abstract][Full Text] [Related]
31. Factors Predicting Survival in ALS Patients--Data from a Population-Based Registry in Rhineland-Palatinate, Germany.
Wolf J; Safer A; Wöhrle JC; Palm F; Nix WA; Maschke M; Grau AJ
Neuroepidemiology; 2015; 44(3):149-55. PubMed ID: 25895515
[TBL] [Abstract][Full Text] [Related]
32. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?
Pena MJ; Ravasco P; Machado M; Pinto A; Pinto S; Rocha L; de Carvalho M; Pinto HC
Amyotroph Lateral Scler; 2012 Oct; 13(6):550-4. PubMed ID: 22708872
[TBL] [Abstract][Full Text] [Related]
33. [Survival prediction and related risk factors of amyotrophic lateral sclerosis:analysis of 65 cases].
Qiao L; Zhang J; Fan DS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):742-5. PubMed ID: 18683681
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.
Traynor BJ; Codd MB; Corr B; Forde C; Frost E; Hardiman OM
Arch Neurol; 2000 Aug; 57(8):1171-6. PubMed ID: 10927797
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
[TBL] [Abstract][Full Text] [Related]
36. A clinical tool for predicting survival in ALS.
Knibb JA; Keren N; Kulka A; Leigh PN; Martin S; Shaw CE; Tsuda M; Al-Chalabi A
J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1361-1367. PubMed ID: 27378085
[TBL] [Abstract][Full Text] [Related]
37. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.
Wolf J; Wöhrle JC; Palm F; Nix WA; Maschke M; Safer A; Becher H; Grau AJ
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):269-74. PubMed ID: 24571628
[TBL] [Abstract][Full Text] [Related]
38. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
Murphy M; Quinn S; Young J; Parkin P; Taylor B
Neurology; 2008 Dec; 71(23):1889-95. PubMed ID: 19047561
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
40. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.
Elamin M; Phukan J; Bede P; Jordan N; Byrne S; Pender N; Hardiman O
Neurology; 2011 Apr; 76(14):1263-9. PubMed ID: 21464431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
